Emerging Treatment Strategies in Advanced Prostate Cancer: The Role for ARPIs

Matthew Smith, MD, PhD, and Brian T. Helfand, MD, introduce themselves and provide clinical insights on screening practices for patients with prostate cancer.

A comprehensive discussion on diagnostic practices in prostate cancer, highlighting imaging practices and the differences between castration-resistant prostate cancer and hormone-sensitive prostate cancer.

Two prostate cancer experts discuss treatment decision-making practices for patients with newly diagnosed metastatic disease.

Comprehensive insights on ARPIs (androgen receptor pathway inhibitors) for the treatment of prostate cancer, highlighting what influences treatment decisions and safety profiles of the available APRIs.

Experts on prostate cancer discuss how treatment has evolved over the years, focusing on doublet and triplet therapy and their utility.

Matthew Smith, MD, PhD, and Brian T. Helfand, MD, discuss the treatment of patients with nonmetastatic castration-resistant prostate cancer.

Focusing on metastatic prostate cancer, 2 experts have a comprehensive discussion on treatment options for patients with metastatic prostate cancer.

Drs Smith and Helfand look ahead and provide their thoughts on future directions in the treatment of patients with prostate cancer.